267 related articles for article (PubMed ID: 21883878)
1. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
3. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
7. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
[TBL] [Abstract][Full Text] [Related]
8. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
[TBL] [Abstract][Full Text] [Related]
11. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
12. Successful use of fondaparinux in the setting of heparin-induced thrombocytopenia with thrombosis confirmed by serotonin-release assay and Factor V Leiden.
Fraielli K; Patel D; Wang D; Sargent K; Gore J
J Clin Pharm Ther; 2019 Oct; 44(5):809-812. PubMed ID: 31486123
[TBL] [Abstract][Full Text] [Related]
13. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
15. Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU.
Harada MY; Hoang DM; Zaw AA; Murry JS; Volod O; Sun BJ; Nuño M; Mason R; Margulies DR; Ley EJ
Crit Care Med; 2017 Jan; 45(1):28-34. PubMed ID: 27513533
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
[TBL] [Abstract][Full Text] [Related]
17. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.
Benken ST; Tillman N; Dajani S; Shah A; Thomas T
J Cardiothorac Surg; 2014 Mar; 9():55. PubMed ID: 24656312
[TBL] [Abstract][Full Text] [Related]
19. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
Warkentin TE; Pai M; Linkins LA
Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]